Description
A metabolite of ellagic acid with antiproliferative, anti-inflammatory, and anti-oxidant properties; decreases proliferation in human endometrial cancer cell lines at a concentration of 1 µM, arrests the cell cycle at the G2/M transition, and modulates estrogen receptor-regulated gene expression; potentiates the antiproliferative effect of 5-fluorouracil; decreases PGE2 levels and prevents upregulation of COX-2 gene expression and protein levels in a rat model of colitis; induces mitophagy, improves fitness, and extends lifespan of C. elegans; increases exercise capacity in mice
Formal name: 3,8-dihydroxy-6H-dibenzo[b,d]pyran-6-one
Synonyms: 2′,7-Dihydroxy-3,4-benzocoumarin|3,8-Dihydroxy Urolithin
Molecular weight: 228.2
CAS: 1143-70-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Natural Products|Polyphenols||Product Type|Biochemicals|Ox Stress Reagents|Antioxidants||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cell Biology|Cell Cycle||Research Area|Cell Biology|Mitochondrial Biology||Research Area|Immunology & Inflammation|Gastric Disease|Ulcerative Colitis||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity||Research Area|Toxicology|Drug Metabolism|Drug Metabolites